April 28, 2011 by admin
The Association for Nurse Prescribing (ANP) has endorsed a free, online, continuing professional development resource, Therapeutics Plus, aimed primarily at non-medical prescribers. It has been developed by Prescriber, NPC Plus and Keele University and is funded by Pfizer. There are modules available now on the management of chronic asthma, neuropathic pain, smoking cessation and chronic obstructive pulmonary disease (COPD) and more will follow.
September 22, 2009 by admin
I recently started a two-year MSc Advanced Practitioner programme with a special interest in COPD, and work with a community COPD team. I qualified as a nurse independent prescriber/nurse supplementary prescriber in 2005, prescribing within my competence in my specialist area. However, my current line manager says I will not be able to prescribe until the end of the course in 2011. I would appreciate your view.
To read the response to this question, click here.
May 1, 2009 by admin
Some studies have recently raised safety concerns about inhaled treatments for chronic obstructive pulmonary disease (COPD): this MeReC Bulletin discusses them and attempts to put them in the context of potential benefits and decision-making factors for individual patients (Volume 19 No 4). The safety issues concern anticholinergics, long-acting beta2 agonists (LABAs) and inhaled corticosteroids and the Bulletin makes clear that these should be considered alongside their potential benefits and side effects, responses to treatment, costs and patients’ preferences. Ultimately, the choice will probably come down to ‘whether the patient can use the device, tolerate the drug and how effective the medication is for their symptoms’.